Delivery Order SPE2DB24D2100-SPE2DB25FBERU
Award Date
6/12/25
Potential Completion Date
6/13/25
Potential Value
$7.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ondansetron HCL 4 MG Tablet 30S. The contract has a firm fixed-price of $3,587.16 and an ultimate completion date of August 2, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,957,266 units of the medication Ondansetron ODT 4 mg tablet. The order has a ceiling value of $5,173.92 and an ultimate completion date of April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
The U.S. government awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,563,358,978 units of Ondansetron HCL 4 mg tablets. The contract has a ceiling value of $12,144.43 and an ultimate completion date of January 22, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supply chain services. AmerisourceBergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 4 MG Tablets 30s, a prescription medication. The contract has a firm fixed price of $4,970.60 and a period of performance through May 20, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,678,777 units of Ondansetron HCL 8 mg tablets. The contract has a ceiling value of $5,996.20 and an ultimate completion date of September 5, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,392,105 units of the pharmaceutical product Ondansetron Hydrochloride 4 MG Tablet. The order has a firm-fixed price of $23,830.40 and a completion date of August 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for the provision of a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,721.55 firm fixed-price delivery order is for the supply of 4,568,188,809 units of the prescription medication Ondansetron HCL 4 MG Tablet, with a completion date of May 9, 2025. The contract is not set-aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,039,700 units of Ondansetron HCL 4 mg tablets, with a firm fixed price ceiling value of $2,090.22. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,164,197 units of the medication Ondansetron ODT 8 mg Tablet. The contract has a ceiling value of $3,567.70 and a performance period through May 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,238,653 units of Ondansetron HCL 4 mg tablets in 30-count packages, with a ceiling value of $2,480.91 and a period of performance through May 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with...